Elite Wins FDA Nod
AllpennyStocks.com

Elite Wins FDA Nod

By: Dylan Sikes – AllPennyStocks.com News

Thursday, September 12, 2019

With the problem of opioid-related deaths becoming an even bigger concern, companies and products fighting such addiction certainly deserve attention. 

Northvale, New Jersery-based Elite Pharmaceuticals, Inc. (OTC:ELTP) is a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products. The company came out Thursday with the news of approval from the U.S. Food and Drug Administration for an Abbreviated New Drug Application for a generic version of Tylenol® with Codeine (acetaminophen and codeine phosphate) 300mg/15mg, 300mg/30mg, and 300mg/60mg tablets.

Elite is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. 

Shares in ELTP popped 67-100ths of a cent, or 9.1%, to eight cents, on volume of 753,000.


Copyright © 2019 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon

Other Penny Stock Movers

Canadian Inflation Moves Up as Expected But Easing Underlying Pressures Boost Hopes of June Rate Cut
 Read More
Shares Up as Firm Launches First Short Spot Bitcoin ETP in the Nordics
 Read More
Could This Stock Be The Next Big Mover In The Short-Term Rental Market?
 Read More
Most Popular
1
Canadian Inflation Moves Up as Expected But Easing Underlying Pressures Boost Hopes of June Rate Cut
2
TSMC posts surge in profits as AI boom boosts high-tech chip sales
3
Shares Up as Firm Launches First Short Spot Bitcoin ETP in the Nordics
4
Micro Cap Massively Bid Up Before Opening Bell
5
Treasury yields pull back further from five-month highs
6
Shares of Dual-Listed Miner Up on News of Options on Uranium Properties
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top
Site Links:
Premium Services / Email Newsletter:
Social Media:
RSS Feed:
Partners:
© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.
© Copyright 1999 – 2024. AllPennyStocks.com Media Inc.
All rights reserved.